All lobbying filings

JIM MASSIE & PARTNERS, LLC

Lobbying for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS · Trade association representing the radionuclide and radiopharmaceutical industry.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Energy/Nuclear

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025 H.R. 5334, Lindsey O. Graham Sanctioning Russia Act of 2026 H.R.2913, Ukraine Support Act

Trade (domestic/foreign)

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

Bills named in this filing 3

S. 1241
Sanctioning Russia Act of 2025
H.R. 5334
Lindsey O. Graham Sanctioning Russia and Iran Act of 2026
H.R. 2913
Ukraine Support Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.